Skip to main content

Che-Chia Hsu

Assistant Professor of Pathology
Pathology
210 Research Drive, GSRB2 Building, Room 4014, Durham, NC 27710
210 Research Drive, GSRB2 Building, Room 4014, Durham, NC 27710

Overview


My research has focused on mitochondrial functions in cancer metabolism and understand the role of mitochondrial dynamics in cellular function and human diseases including cancers. Additionally, I also continuously dissect cancer metabolism and identifying potential metabolic vulnerabilities of cancer initiation, progression and metastasis using several in vitroex vivo and in vivo genetical approaches such as CRISPR/Cas9 knockout, mouse/ human organoid cultures and genetically engineered mouse models, thereby characterizing molecular mechanisms regulated by metabolic pathways and developing potential metabolic interventions for targeting cancers. 

Current Appointments & Affiliations


Assistant Professor of Pathology · 2023 - Present Pathology, Clinical Science Departments
Member of the Duke Cancer Institute · 2024 - Present Duke Cancer Institute, Institutes and Centers

Recent Publications


IMPA1-derived inositol maintains stemness in castration-resistant prostate cancer via IMPDH2 activation.

Journal Article J Exp Med · November 4, 2024 Acquisition of prostate cancer stem cells (PCSCs) manifested during androgen ablation therapy (ABT) contributes to castration-resistant prostate cancer (CRPC). However, little is known about the specific metabolites critically orchestrating this process. H ... Full text Link to item Cite

NSUN2 is a glucose sensor suppressing cGAS/STING to maintain tumorigenesis and immunotherapy resistance.

Journal Article Cell Metab · October 3, 2023 Glucose metabolism is known to orchestrate oncogenesis. Whether glucose serves as a signaling molecule directly regulating oncoprotein activity for tumorigenesis remains elusive. Here, we report that glucose is a cofactor binding to methyltransferase NSUN2 ... Full text Link to item Cite

Deregulated transcription factors in cancer cell metabolisms and reprogramming.

Journal Article Semin Cancer Biol · November 2022 Metabolic reprogramming is an important cancer hallmark that plays a key role in cancer malignancies and therapy resistance. Cancer cells reprogram the metabolic pathways to generate not only energy and building blocks but also produce numerous key signali ... Full text Link to item Cite
View All Publications

Education, Training & Certifications


National Cheng Kung University (Taiwan) · 2014 Ph.D.